Sven-Erik Svehag
Corporate Officer/Principal at University of Southern Denmark
Profile
Sven-Erik Svehag is currently working as a Principal at the World Health Organization, a Professor at the University of Southern Denmark, and an Associate Professor at the National Bact.
Laboratory.
Previously, he worked as the Chief Executive Officer at Profylakse ApS and as the President of the Scandinavian Society of Immunology.
Sven-Erik Svehag active positions
Companies | Position | Start |
---|---|---|
University of Southern Denmark | Corporate Officer/Principal | - |
World Health Organization
World Health Organization SupranationalGovernment World Health Organization provides voluntary medical services. It is the United Nations' agency for health. WHO is governed by countries that approve funding, programs and policies related to public health and health related social issues through the world health assembly. Some of the health and social issues which the organization addresses are communicable & non-communicable diseases, community & family health, hunger, health technology, mental health, pharmaceuticals and sustainable development. Founded on April 7, 1948, the organization is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | - |
National Bact. Laboratory | Corporate Officer/Principal | 14/08/2009 |
Former positions of Sven-Erik Svehag
Companies | Position | End |
---|---|---|
Profylakse ApS
Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Chief Executive Officer | 22/11/2013 |
Scandinavian Society of Immunology | President | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
World Health Organization
World Health Organization SupranationalGovernment World Health Organization provides voluntary medical services. It is the United Nations' agency for health. WHO is governed by countries that approve funding, programs and policies related to public health and health related social issues through the world health assembly. Some of the health and social issues which the organization addresses are communicable & non-communicable diseases, community & family health, hunger, health technology, mental health, pharmaceuticals and sustainable development. Founded on April 7, 1948, the organization is headquartered in Geneva, Switzerland. | Government |
Profylakse ApS
Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Health Technology |
Scandinavian Society of Immunology | |
National Bact. Laboratory |
- Stock Market
- Insiders
- Sven-Erik Svehag